FDA approves first brain stimulation device for home depression treatment. Flow Neuroscience's FL-100 headset uses electrical ...

The first-of-a-kind brain-stimulation device approved to treat attention-deficit/hyperactivity disorder (ADHD) in the US has ...

HOUSTON, TX, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office ...

WILLOW SPRINGS, Ill. (WGN) — There has been an extraordinary step forward in the treatment of spinal cord injuries. For the patients who come through the door of the Next Steps clinic in southwest ...

The randomized, double-blind, sham-controlled trial evaluated 56 adults with ADHD who received four weeks of Nexalin’s ...

When treatments such as medication and therapy aren’t able to relieve the symptoms of depression or another mental health condition, there are other options available. A psychiatrist might suggest ...

Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced that it has received a ...

A large multicenter clinical trial led by King's College London with 150 children and adolescents has shown that a device ...

A large-scale clinical trial has determined that a specific brain stimulation device, previously cleared by regulators for ...

HOUSTON, TEXAS, June 20, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced that the United States Patent and Trademark Office ...